Healthcare - Medical - Care Facilities - NASDAQ - US
$ 0.18
-23.5 %
$ 13.6 M
Market Cap
-0.23
P/E
CASH FLOW STATEMENT
-36.3 M
OPERATING CASH FLOW
62.6 M
INVESTING CASH FLOW
-6.85 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
The Oncology Institute, Inc.
| Net Income | -83.1 M |
| Depreciation & Amortization | 5.87 M |
| Capital Expenditures | -4.57 M |
| Stock-Based Compensation | 17.8 M |
| Change in Working Capital | 2.36 M |
| Others | 27 M |
| Free Cash Flow | -40.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (83.1) | 1.7 | (10.9) | (14.3) | (4.0) | 3.9 |
| Depreciation & Amortization | 5.9 | 4.4 | 3.3 | 3.2 | 2.9 | 1.1 |
| Deferred Income Tax | 76 K | 0.2 | (1.2) | (1.3) | 0.8 | 0.7 |
| Stock Based Compensation | 17.8 | 27.7 | 24.5 | 0.2 | 94 K | 0 |
| Other Operating Activities | 20.8 | (75.2) | (33.9) | 11.9 | 0.3 | 6.9 |
| Change in Working Capital | 2.4 | (20.5) | (14.5) | 1.0 | 3.4 | 97.6 K |
| Cash From Operations | (36.3) | (61.8) | (32.7) | 0.5 | 3.6 | 5.6 |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (4.6) | (5.5) | (3.0) | (1.2) | (1.2) | (0.7) |
| Other Items | 67.2 | (126.1) | (9.1) | (7.7) | 0 | 3.2 |
| Cash From Investing Activities | 62.6 | (131.6) | (12.2) | (8.8) | (1.2) | 2.5 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | (1.0) | (9.0) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.1) | 109.9 | (7.3) | 12.2 | 1.81 K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | (8.2) |
| Other Financing Activities | (5.7) | (8.7) | 161.3 | (0.3) | 0 | 0 |
| Cash From Financing Activities | (6.8) | 92.2 | 154.0 | 11.9 | 1.81 K | (8.2) |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 19.5 | (101.2) | 109.2 | 3.6 | 2.4 | 14.7 K |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (40.9) | (67.3) | (35.7) | (0.7) | 2.4 | 4.9 |